Cargando…
Emerging therapies in primary sclerosing cholangitis: pathophysiological basis and clinical opportunities
Primary sclerosing cholangitis (PSC) is a progressive liver disease, histologically characterized by inflammation and fibrosis of the bile ducts, and clinically leading to multi-focal biliary strictures and with time cirrhosis and liver failure. Patients bear a significant risk of cholangiocarcinoma...
Autores principales: | Vesterhus, Mette, Karlsen, Tom Hemming |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Singapore
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7242240/ https://www.ncbi.nlm.nih.gov/pubmed/32222826 http://dx.doi.org/10.1007/s00535-020-01681-z |
Ejemplares similares
-
Fluctuating biomarkers in primary sclerosing cholangitis: A longitudinal comparison of alkaline phosphatase, liver stiffness, and ELF
por: Fossdal, Guri, et al.
Publicado: (2021) -
Suppression of bile acid synthesis as a tipping point in the disease course of primary sclerosing cholangitis
por: Braadland, Peder Rustøen, et al.
Publicado: (2022) -
Autotaxin activity predicts transplant-free survival in primary sclerosing cholangitis
por: Dhillon, Amandeep K., et al.
Publicado: (2019) -
Circulating Macrophage Activation Markers Predict Transplant-Free Survival in Patients With Primary Sclerosing Cholangitis
por: Bossen, Lars, et al.
Publicado: (2021) -
Cholangiocytes and the environment in primary sclerosing cholangitis: where is the link?
por: O’Hara, Steven P, et al.
Publicado: (2017)